Literature DB >> 24047466

Sirtuin 3 deficiency does not augment hypoxia-induced pulmonary hypertension.

Gregory B Waypa1, Scott W Osborne, Jeremy D Marks, Sara K Berkelhamer, Jyothisri Kondapalli, Paul T Schumacker.   

Abstract

Alveolar hypoxia elicits increases in mitochondrial reactive oxygen species (ROS) signaling in pulmonary arterial (PA) smooth muscle cells (PASMCs), triggering hypoxic pulmonary vasoconstriction. Mice deficient in sirtuin (Sirt) 3, a nicotinamide adenine dinucleotide-dependent mitochondrial deacetylase, demonstrate enhanced left ventricular hypertrophy after aortic banding, whereas cells from these mice reportedly exhibit augmented hypoxia-induced ROS signaling and hypoxia-inducible factor (HIF)-1 activation. We therefore tested whether deletion of Sirt3 would augment hypoxia-induced ROS signaling in PASMCs, thereby exacerbating the development of pulmonary hypertension (PH) and right ventricular hypertrophy. In PASMCs from Sirt3 knockout (Sirt3(-/-)) mice in the C57BL/6 background, we observed that acute hypoxia (1.5% O2; 30 min)-induced changes in ROS signaling, detected using targeted redox-sensitive, ratiometric fluorescent protein sensors (roGFP) in the mitochondrial matrix, intermembrane space, and the cytosol, were indistinguishable from Sirt3(+/+) cells. Acute hypoxia-induced cytosolic calcium signaling in Sirt3(-/-) PASMCs was also indistinguishable from Sirt3(+/+) cells. During sustained hypoxia (1.5% O2; 16 h), Sirt3 deletion augmented mitochondrial matrix oxidant stress, but this did not correspond to an augmentation of intermembrane space or cytosolic oxidant signaling. Sirt3 deletion did not affect HIF-1α stabilization under normoxia, nor did it augment HIF-1α stabilization during sustained hypoxia (1.5% O2; 4 h). Sirt3(-/-) mice housed in chronic hypoxia (10% O2; 30 d) developed PH, PA wall remodeling, and right ventricular hypertrophy that was indistinguishable from Sirt3(+/+) littermates. Thus, Sirt3 deletion does not augment hypoxia-induced ROS signaling or its consequences in the cytosol of PASMCs, or the development of PH. These findings suggest that Sirt3 responses may be cell type specific, or restricted to certain genetic backgrounds.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24047466      PMCID: PMC3931121          DOI: 10.1165/rcmb.2013-0191OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  43 in total

Review 1.  Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1.

Authors:  G L Semenza
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

2.  Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing.

Authors:  N S Chandel; D S McClintock; C E Feliciano; T M Wood; J A Melendez; A M Rodriguez; P T Schumacker
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

Review 3.  SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging.

Authors:  Albert Giralt; Francesc Villarroya
Journal:  Biochem J       Date:  2012-05-15       Impact factor: 3.857

Review 4.  HIF-1: mediator of physiological and pathophysiological responses to hypoxia.

Authors:  G L Semenza
Journal:  J Appl Physiol (1985)       Date:  2000-04

Review 5.  HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus.

Authors:  G L Semenza
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

6.  Ca(2+) release from ryanodine-sensitive store contributes to mechanism of hypoxic vasoconstriction in rat lungs.

Authors:  Yoshiteru Morio; Ivan F McMurtry
Journal:  J Appl Physiol (1985)       Date:  2002-02

7.  Mitochondrial reactive oxygen species trigger calcium increases during hypoxia in pulmonary arterial myocytes.

Authors:  Gregory B Waypa; Jeremy D Marks; Mathew M Mack; Chan Boriboun; Paul T Mungai; Paul T Schumacker
Journal:  Circ Res       Date:  2002-10-18       Impact factor: 17.367

8.  Divergent roles of glycolysis and the mitochondrial electron transport chain in hypoxic pulmonary vasoconstriction of the rat: identity of the hypoxic sensor.

Authors:  R M Leach; H M Hill; V A Snetkov; T P Robertson; J P Ward
Journal:  J Physiol       Date:  2001-10-01       Impact factor: 5.182

9.  Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing.

Authors:  G B Waypa; N S Chandel; P T Schumacker
Journal:  Circ Res       Date:  2001-06-22       Impact factor: 17.367

Review 10.  Reactive oxygen species in cell signaling.

Authors:  V J Thannickal; B L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-12       Impact factor: 5.464

View more
  13 in total

Review 1.  Redox biology in pulmonary arterial hypertension (2013 Grover Conference Series).

Authors:  Joshua P Fessel; James D West
Journal:  Pulm Circ       Date:  2015-12       Impact factor: 3.017

2.  Metabolism and Redox in Pulmonary Vascular Physiology and Pathophysiology.

Authors:  Norah Alruwaili; Sharath Kandhi; Dong Sun; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2018-12-21       Impact factor: 8.401

3.  Mitochondrial Dysfunction: Metabolic Drivers of Pulmonary Hypertension.

Authors:  Hagir B Suliman; Eva Nozik-Grayck
Journal:  Antioxid Redox Signal       Date:  2019-02-25       Impact factor: 8.401

4.  Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension.

Authors:  Eva Nozik-Grayck; Crystal Woods; Robert S Stearman; Sujatha Venkataraman; Bradley S Ferguson; Kalin Swain; Russell P Bowler; Mark W Geraci; Kaori Ihida-Stansbury; Kurt R Stenmark; Timothy A McKinsey; Frederick E Domann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-27       Impact factor: 5.464

5.  SIRT3 Mediates the Antioxidant Effect of Hydrogen Sulfide in Endothelial Cells.

Authors:  Liping Xie; Haihua Feng; Sha Li; Guoliang Meng; Shangmin Liu; Xin Tang; Yan Ma; Yi Han; Yujiao Xiao; Yue Gu; Yongfeng Shao; Chung-Min Park; Ming Xian; Yu Huang; Albert Ferro; Rui Wang; Philip K Moore; Hong Wang; Yong Ji
Journal:  Antioxid Redox Signal       Date:  2015-11-10       Impact factor: 8.401

Review 6.  'There and Back Again'-Forward Genetics and Reverse Phenotyping in Pulmonary Arterial Hypertension.

Authors:  Emilia M Swietlik; Matina Prapa; Jennifer M Martin; Divya Pandya; Kathryn Auckland; Nicholas W Morrell; Stefan Gräf
Journal:  Genes (Basel)       Date:  2020-11-26       Impact factor: 4.096

7.  Design considerations for open-well microfluidic platforms for hypoxic cell studies.

Authors:  Matthew B Byrne; Matthew T Leslie; Heeral S Patel; H Rex Gaskins; Paul J A Kenis
Journal:  Biomicrofluidics       Date:  2017-10-27       Impact factor: 2.800

8.  SIRT1 is required for mitochondrial biogenesis reprogramming in hypoxic human pulmonary arteriolar smooth muscle cells.

Authors:  Pengyun Li; Yan Liu; Nana Burns; Ke-Seng Zhao; Rui Song
Journal:  Int J Mol Med       Date:  2017-03-22       Impact factor: 4.101

9.  Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension.

Authors:  Robert A Egnatchik; Evan L Brittain; Amy T Shah; Wassim H Fares; H James Ford; Ken Monahan; Christie J Kang; Emily G Kocurek; Shijun Zhu; Thong Luong; Thuy T Nguyen; Erik Hysinger; Eric D Austin; Melissa C Skala; Jamey D Young; L Jackson Roberts; Anna R Hemnes; James West; Joshua P Fessel
Journal:  Pulm Circ       Date:  2017-02-01       Impact factor: 3.017

Review 10.  SIRT3: A New Regulator of Cardiovascular Diseases.

Authors:  Wei Sun; Caixia Liu; Qiuhui Chen; Ning Liu; Youyou Yan; Bin Liu
Journal:  Oxid Med Cell Longev       Date:  2018-02-13       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.